Loading…
Loading…
By Christopher Gannatti, CFA, Global Head of Research Key Takeaways In Q1 2025, the WisdomTree Efficient Gold Plus Gold Miners Strategy Fund (GDMN) led all performers, benefiting from a capital-efficient structure that captured gains in both gold futures and gold mining equities amid persistent inflation concerns and geopolitical instability.
By Christopher Gannatti, CFA Key Takeaways Recent advancements in GLP-1 drugs, such as Ozempic and Wegovy, underscore their potential to transform health care by addressing obesity, cardiovascular diseases and even neurodegenerative conditions.
By Christopher Gannatti, CFA, Global Head of Research We have been writing a lot about artificial intelligence (AI) and the ways in which we believe that topic will continue to evolve as the calendar changes from 2023 to 2024.
It's been a lengthy of stretch of subpar performance by biotech stocks and related exchange traded funds. That's a scenario that will repeat this year.
The healthcare sector is disappointing this year. And the ICE Biotechnology Index is even more of a dud on a year-to-date basis.
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
There are European politicians expressing support for the use of genetic modification techniques in agriculture. A certain bug-resistant strain of corn is the only genetically modified crop that has been grown within the European Union, based on the current highly restrictive rules.
President Biden spoke at the Kennedy Presidential Library on the 60th anniversary of JFK's moonshot speech on Monday, September 12, outlining his plans for building out American research to end cancer, which he describes as his own personal presidential moonshot, reported NPR.